Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
Li2CO3
CAS Number:
Molecular Weight:
73.89
EC Number:
209-062-5
UNSPSC Code:
12352300
PubChem Substance ID:
Beilstein/REAXYS Number:
3999191
MDL number:
product line
BioXtra
assay
~99%
impurities
≤0.01% Phosphorus (P), ≤0.1% Insoluble matter
mp
618 °C (lit.)
anion traces
chloride (Cl-): ≤0.005%, sulfate (SO42-): ≤0.005%
cation traces
Al: ≤0.0005%, Ca: ≤0.002%, Cu: ≤0.0005%, Fe: ≤0.003%, K: ≤0.01%, Mg: ≤0.01%, NH4+: ≤0.05%, Na: ≤0.05%, Pb: ≤0.001%, Zn: ≤0.0005%
SMILES string
[Li+].[Li+].[O-]C([O-])=O
InChI
1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2
InChI key
XGZVUEUWXADBQD-UHFFFAOYSA-L
Still not finding the right product?
Explore all of our products under Lithium carbonate
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2
Storage Class
13 - Non Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
K E Morrison et al.
The Lancet. Neurology, 12(4), 339-345 (2013-03-05)
Lithium has neuroprotective effects in cell and animal models of amyotrophic lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant effect of lithium on survival. We aimed to assess whether lithium improves survival in
Andrea Contestabile et al.
The Journal of clinical investigation, 123(1), 348-361 (2012-12-04)
Down syndrome (DS) patients exhibit abnormalities of hippocampal-dependent explicit memory, a feature that is replicated in relevant mouse models of the disease. Adult hippocampal neurogenesis, which is impaired in DS and other neuropsychiatric diseases, plays a key role in hippocampal
Tom Bschor et al.
Journal of clinical psychopharmacology, 33(1), 38-44 (2013-01-02)
Studies of the 1970s and 1980s showed lithium monotherapy to be an effective treatment of acute unipolar major depressive disorder (MDD) and hence as a potential alternative to monoaminergic antidepressants.The objective was to conduct the first comparison of a lithium
